Tag: CGuard EPS
January 24, 2019
InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study
InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of... January 14, 2019
InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa
InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of... September 21, 2017
InspireMD Announces Distribution Agreement in Portugal
InspireMD announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a medical distributor in Portugal, to distribute... August 3, 2017
InspireMD's CGuard System Featured at Cardiology Congress
InspireMD announced the endovascular interventional procedure which features the CGuard EPS was recorded and presented at this year's SOLACI CACI... June 5, 2017
InspireMD Signs Distribution Agreement with Arteriae
InspireMD signed an agreement with Arteriae, a medical distributor leader in Poland, to distribute CGuard Embolic Prevention System. May 31, 2017
InspireMD's CGuard EPS Treats Patients in Hong Kong
InspireMD announced the positive treatment of two patients in Hong Kong using CGuard EPS. May 17, 2017